UnitedHealth Group Inc. (UNH) Scheduled to Post Earnings on Tuesday
UnitedHealth Group Inc. (NYSE:UNH) is scheduled to announce its Q316 earnings results on Tuesday, October 18th. Analysts expect the company to announce earnings of $2.08 per share and revenue of $46.11 billion for the quarter.
Shares of UnitedHealth Group Inc. (NYSE:UNH) opened at 133.92 on Monday. The company has a 50 day moving average of $137.02 and a 200 day moving average of $136.52. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48. The company has a market cap of $127.54 billion, a PE ratio of 20.96 and a beta of 0.57.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.87%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
Several analysts recently issued reports on the company. Jefferies Group reaffirmed a “buy” rating and set a $163.00 price objective on shares of UnitedHealth Group in a research report on Sunday. Vetr raised UnitedHealth Group from a “buy” rating to a “buy” rating in a research report on Friday, October 7th. Evercore ISI began coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They set a “buy” rating and a $155.00 price objective on the stock. Cowen and Company set a $150.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, September 6th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $178.00 target price on shares of UnitedHealth Group in a report on Tuesday, September 6th. One research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.65% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in UNH. 1832 Asset Management L.P. purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $213,354,000. Bessemer Group Inc. boosted its position in UnitedHealth Group by 934.0% in the second quarter. Bessemer Group Inc. now owns 534,907 shares of the healthcare conglomerate’s stock worth $75,529,000 after buying an additional 483,173 shares in the last quarter. Marshall Wace LLP boosted its position in UnitedHealth Group by 65.9% in the second quarter. Marshall Wace LLP now owns 718,220 shares of the healthcare conglomerate’s stock worth $101,412,000 after buying an additional 285,242 shares in the last quarter. Numeric Investors LLC boosted its position in UnitedHealth Group by 185.5% in the second quarter. Numeric Investors LLC now owns 422,000 shares of the healthcare conglomerate’s stock worth $59,586,000 after buying an additional 274,200 shares in the last quarter. Finally, State of Tennessee Treasury Department boosted its position in UnitedHealth Group by 33.5% in the second quarter. State of Tennessee Treasury Department now owns 993,328 shares of the healthcare conglomerate’s stock worth $140,258,000 after buying an additional 248,994 shares in the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.